OSMOPREP- sodium phosphate, monobasic, monohydrate, sodium phosphate, dibasic anhydrous tablet 美国 - 英文 - NLM (National Library of Medicine)

osmoprep- sodium phosphate, monobasic, monohydrate, sodium phosphate, dibasic anhydrous tablet

physicians total care, inc. - sodium phosphate, monobasic, monohydrate (unii: 593yog76rn) (sodium cation - unii:lyr4m0nh37), sodium phosphate, dibasic anhydrous (unii: 22ado53m6f) (sodium cation - unii:lyr4m0nh37) - sodium cation 1.102 g - osmoprep tablets are indicated for cleansing of the colon as a preparation for colonoscopy in adults 18 years of age or older. osmoprep tablets are contraindicated in patients with biopsy-proven acute phosphate nephropathy. osmoprep tablets are contraindicated in patients with a known allergy or hypersensitivity to sodium phosphate salts or any of its ingredients. laxatives and purgatives (including osmoprep) have the potential for abuse by bulimia nervosa patients who frequently have binge eating and vomiting.

POTASSIUM PHOSPHATES- potassium phosphate, monobasic and potassium phosphate, dibasic injection, solution, concentrate 美国 - 英文 - NLM (National Library of Medicine)

potassium phosphates- potassium phosphate, monobasic and potassium phosphate, dibasic injection, solution, concentrate

hospira, inc. - monobasic potassium phosphate (unii: 4j9fj0hl51) (potassium cation - unii:295o53k152, phosphate ion - unii:nk08v8k8hr), dibasic potassium phosphate (unii: ci71s98n1z) (phosphate ion - unii:nk08v8k8hr, potassium cation - unii:295o53k152) - potassium phosphate, monobasic 224 mg in 1 ml - potassium phosphates injection, usp, 3 mm p/ml is indicated as a source of phosphorus, for addition to large volume intravenous fluids, to prevent or correct hypophosphatemia in patients with restricted or no oral intake. it is also useful as an additive for preparing specific intravenous fluid formulas when the needs of the patient cannot be met by standard electrolyte or nutrient solutions. the concomitant amount of potassium (k+ 4.4 meq/ml) must be calculated into total electrolyte dose of such prepared solutions.     safety has not been established for parenteral nutrition in pediatric patients due to the risk of aluminum toxicity. (see warnings) potassium phosphate is contraindicated in diseases where high potassium, high phosphorus or low calcium levels may be encountered.

Basic walker, foldable 澳大利亚 - 英文 - Department of Health (Therapeutic Goods Administration)

basic walker, foldable

bespoke engineering - 37951 - basic walker, foldable - basic walker foldable gmdn code 37951. an all- or partially-wheeled mobility aid in the form of a waist-high, foldable framework with handgrips and four or three legs designed to provide a stable support to a person with a disability, a geriatric or an infirm person when standing or ambulating; it may also be used during rehabilitation. it is constructed of lightweight metal, plastic, and rubber materials and in the form of a mobile support structure which the user holds and pushes in front of them as they walk. it is foldable for storage and transportation, and includes a braking mechanism; it may be width-adjustable and some types may include a seat on which the user can rest.

Sinon Tribasic Flowable Copper Fungicide 澳大利亚 - 英文 - APVMA (Australian Pesticides and Veterinary Medicines Authority)

sinon tribasic flowable copper fungicide

sinon australia pty limited - copper (cu) present as tribasic copper sulphate - suspension concentrate - copper (cu) present as tribasic copper sulphate mineral-copper active 190.0 g/l - fungicide

Kenso Agcare Tribasic Copper Flowable Fungicide 澳大利亚 - 英文 - APVMA (Australian Pesticides and Veterinary Medicines Authority)

kenso agcare tribasic copper flowable fungicide

kenso corporation (m) sdn. bhd. - copper (cu) present as tribasic copper sulphate - suspension concentrate - copper (cu) present as tribasic copper sulphate mineral-copper active 190.0 g/l - fungicide

Phosphate Phebra 澳大利亚 - 英文 - Department of Health (Therapeutic Goods Administration)

phosphate phebra

phebra pty ltd - monobasic sodium phosphate, quantity: 1.936 g - tablet, effervescent - excipient ingredients: potassium bicarbonate; citric acid; sucrose; macrogol 4000; saccharin sodium; sodium bicarbonate; flavour - 1) hypercalcaemia associated with such conditions as hyperparathyroidism, multiple myelomatosis, and metastatic bone disease.,2) hypophosphataemia associated with vitamin d resistant rickets.

PHOSPHO-SODA oral solution bottle 澳大利亚 - 英文 - Department of Health (Therapeutic Goods Administration)

phospho-soda oral solution bottle

chiesi australia pty ltd - dibasic sodium phosphate, quantity: 4.3 g; monobasic sodium phosphate, quantity: 18.8 g - oral liquid - excipient ingredients: glycerol; saccharin sodium; sodium benzoate; purified water; flavour - for use as part of a bowel cleansing regimen in preparing adult patients for colon surgery or for preparing the colon for x-ray or endoscopic examination.

BASIC 12 LIQUID 10.8% 加拿大 - 英文 - Health Canada

basic 12 liquid 10.8%

basic packaging industries inc. - sodium hypochlorite - liquid - 10.8% - sodium hypochlorite 10.8% - disinfectants (for agents used on object)